Research Topics
| G B MiglioriSummaryAffiliation: Fondazione Salvatore Maugeri Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study GroupG B Migliori
Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
Bull World Health Organ 76:475-83. 1998..Decision-makers and health administrators should be responsible for re-investing the financial and human resources mobilized by the adoption of cost-effective strategies within the TB control programme...
Drug-resistant tuberculosisEmanuele Pontali
Department of Infectious Diseases, Galliera Hospital, Genova, Italy
Curr Opin Pulm Med 19:266-72. 2013..This review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis (TB), an area where solutions for better diagnosis and treatment continually develop...- European union standards for tuberculosis careG B Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049 Tradate, Italy
Eur Respir J 39:807-19. 2012..These will support EU health programmes to identify and develop optimal procedures for TB care, control and elimination... - Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina FasoPaolo Miotto
Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy
BMC Infect Dis 9:142. 2009.... - Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis casesG B Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
Eur Respir J 31:1155-9. 2008..As Mycobacterium tuberculosis drug resistance is increasing worldwide, there is an urgent need for novel interventions in the fight against tuberculosis... - Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectivesGiovanni Battista Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
Curr Opin Pulm Med 16:171-9. 2010.... - Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and controlGiovanni Battista Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute TBNET Secretariat TuBerculosis Network European Trialsgroup Stop TB Italy, via Roncaccio 16, 21049, Tradate, Italy
Clin Chest Med 30:637-65, vii. 2009..Adherence to internationally agreed standards of care and control practices is imperative to achieve TB control... 
Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in ItalyG B Migliori
Fondazione Salvatore Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, Tradate, VA, Italy
Eur J Epidemiol 16:719-24. 2000..The importance of further disseminating national guidelines among physicians managing TB is emphasized, in order to achieve a higher proportion of TB cases bacteriologically confirmed at diagnosis and monitored at the end of treatment...- Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study GroupG B Migliori
Fondazione S Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, Tradate, Italy
Int J Tuberc Lung Dis 4:940-6. 2000..To determine the accuracy of drug-susceptibility testing (DST) for isoniazid, rifampicin, ethambutol and streptomycin in a provisional network of 22 regional laboratories in Italy... - Clinical and operational value of the extensively drug-resistant tuberculosis definitionG B Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate, Italy
Eur Respir J 30:623-6. 2007.... - TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?G B Migliori
WHO Collaborating Centre forTuberculosis and Lung Diseases, Fondazione S Maugeri, Care andReasearch Institute, Tradate, Italy
Eur Respir J 39:619-25. 2012..Training, increased awareness, promotion of standards and allocation of appropriate resources are necessary to ensure appropriate care and management as well as to prevent further emergence of drug resistance... - Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000G B Migliori
World Health Organization WHO Collaborating Centre for Tuberculosis and Lung Diseases, Dept of Pneumonology, S Maugeri Foundation, Care and Research Institute, Tradate, Italy
Eur Respir J 21:129-34. 2003..9 to 2%). The significant association found between isoniazid resistance and immigration is a useful indicator for both clinicians managing individual tuberculosis cases and public health services planning control strategies... - A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosisG B Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy
Eur Respir J 34:387-93. 2009..Its safety profile does not warrant use in cases for which there are other, safer, alternatives... - Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring toolG B Migliori
Fondazione S Maugeri, Care and Research Institute, World Health Organization Collaborating Centre for TB and Lung Diseases, Tradate, Italy
Int J Tuberc Lung Dis 13:1305-8. 2009..This GLC-endorsed tool supports global efforts to contain MDR/XDR-TB and is useful in developing national MDR/XDR-TB control strategies... - First tuberculosis cases in Italy resistant to all tested drugsG B Migliori
WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
Euro Surveill 12:E070517.1. 2007 - Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study GroupG B Migliori
Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
Bull World Health Organ 77:467-76. 1999.... - The best on infections: update from the 2010 ERS CongressM Miravitlles
Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic, Ciber de enfermedades respiratorias CIBERES, Barcelona, Spain
Eur Respir J 38:450-5. 2011.... - Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarctionR F Pedretti
Fondazione Salvatore Maugeri, Care and Research Institute, Administrative Department, Rehabilitation Institute, Tradate, Italy
J Am Coll Cardiol 31:1481-9. 1998..noninvasive and electrophysiologic testing) on survival benefit and cost-effectiveness ratio of amiodarone therapy... - Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapyG B Migliori
WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy
Int J Tuberc Lung Dis 6:858-64. 2002..Ivanovo Oblast, Russian Federation, 300 km north-east of Moscow, where a pilot DOTS TB control programme was implemented in October 1995... - Problems to control TB in eastern Europe and consequences in low incidence countriesG B Migliori
WHO Collaborating Centre for Tuberculosis and Lung Diseases, Pneumology Department, S Maugeri Foundation, IRCCS, via Roncaccio 16, 21049, Tradate, Varese, Italy
Monaldi Arch Chest Dis 57:285-90. 2002..As opportunities for improved funding of TB control in the region exist, there is the potential to reverse to TB pandemic before the explosion of the HIV epidemic expected in Eastern Europe... - Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in ItalyG B Migliori
WHO Collaborating Centre for Control of Tuberculosis and Lung Diseases in Europe Department of Pnuemology, Tradate, Italy
Int J Tuberc Lung Dis 6:32-8. 2002.... - Evaluation of tuberculosis treatment results in Italy, report 1999R Centis
WHO Collaborating Centre for Tuberculosis and Lung Diseases, Dept. of Pneumology, Fondazione S. Maugeri, Clinica del Lavoro e della Riabilitazione, Care and Research Institute, via Roncaccio 16, 21049, Tradate, VA, Italy
Monaldi Arch Chest Dis 57:297-305. 2002..A significantly higher percentage of deaths were recorded amongst native Italians (being age-related; p < 0.001) while immigrants had a higher default rate (p < 0.001)... - 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?G B Migliori
Eur Respir J 29:423-7. 2007 - Management of multidrug-resistant tuberculosis in ItalyG Ferrara
Respiratory Diseases Section, University of Modena and Reggio Emilia, Modena, Italy
Int J Tuberc Lung Dis 9:507-13. 2005..CONCLUSION: The best available treatment should be provided to all newly diagnosed MDR-TB patients, avoiding the use of poorly modified regimens. MDR-TB patients should be referred to highly specialised centres... - Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?G B Migliori
Eur Respir J 31:904-5. 2008 - Tuberculosis, one disease, many facesG B Migliori
Monaldi Arch Chest Dis 69:2-4. 2008 - External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countriesL Fattorini
Istituto Superiore di Sanita, Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Rome, Italy
Int J Tuberc Lung Dis 12:214-7. 2008..Quality assurance for the World Health Organization (WHO)/International Union Against Tuberculosis and Lung Disease (The Union) global tuberculosis (TB) drug resistance surveillance programme... - European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis AsJ F Broekmans
Royal Netherlands Tuberculosis Association, The Hague, The Netherlands
Eur Respir J 19:765-75. 2002..g. through screening and bacille Calmette-Guéria immunization in specified groups), surveillance and treatment outcome monitoring are prerequisites to implementing the policy package recommended in this new framework document... - Epidemiology and control of tuberculosis in Western European citiesL R Codecasa
Int J Tuberc Lung Dis 8:1275-6. 2004 - Comparison of tuberculin skin test and Quantiferon immunological assay for latent tuberculosis infectionL R Codecasa
Lombardia Region TB Reference Clinic and Laboratory, Villa Marelli Institute, Niguarda Hospital, Milano, Italy
Monaldi Arch Chest Dis 63:158-62. 2005..Quantiferon does not seem to have brought significant improvement in the diagnosis of LTBI... - Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosisFederica Piana
Am J Respir Crit Care Med 173:130; author reply 130-1. 2006 - Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patientsF Piana
Emerging Bacterial Pathogens Unit, San Raffaele-Turro, Via Stamira d'Ancona 20, 20127 Milan, Italy
Eur Respir J 28:31-4. 2006..This study suggests that the T-SPOT.TB test maintains its sensitivity and performance in immunocompromised patients, identifying a large number of truly infected patients anergic to the tuberculin skin test... - Tuberculosis care and controlPhilip C Hopewell
Bull World Health Organ 84:428. 2006 - Improving the TB case management: The International Standards for Tuberculosis CareG B Migliori
Eur Respir J 28:687-90. 2006 - Ripped from the headlines: how can we harness communications to control TB?G B Migliori
Eur Respir J 30:194-8. 2007 - Survey of BCG vaccination policy in Europe: 1994-96L Trnka
Tuberculosis Surveillance Unit, Clinic of Pneumology and Chest Surgery, University Hospital, Prague Bulovka, Czech Republic
Bull World Health Organ 76:85-91. 1998..Preventive methods whose cost-effectiveness has not been properly established should be discouraged...